RBC lifts Morgan Stanley stock price target to $142 from $122
RBC Capital Markets adjusted their outlook on Morgan Stanley (NYSE:MS) shares, raising the price target from $122.00 to ...
RBC Capital cuts Intra-Cellular stock rating, hikes target to $132
RBC Capital Markets adjusted its stance on Intra-Cellular Therapies shares, downgrading the biopharmaceutical company from Outperform to Sector Perform. The firm, however, raised its price target on ...
RBC Capital Remains a Sell on abrdn (ABDN)
RBC Capital analyst Mandeep Jagpal maintained a Sell rating on abrdn (ABDN – Research Report) today and set a price target of p135.00. The ...
RegenXBio (RGNX) Gets a Buy from RBC Capital
RBC Capital analyst Luca Issi maintained a Buy rating on RegenXBio (RGNX – Research Report) today and set a price target of $30.00. The ...
Robinhood moved to top pick at Morgan Stanley on growth opportunity; stock rises
Robinhood fined $65 million by SEC. Analysts bullish on company's growth potential in crypto industry under incoming Trump ...
Morgan Stanley shares pop as dealmaking drives record revenue under first-year CEO
The CEO also said he is ‘bullish’ on the potential for stock sales, including initial public offerings in 2025.
Q4 2024 Morgan Stanley Earnings Call
Daniel Fannon; Analyst; Jefferies & Company Inc. Gerard Cassidy; Analyst; RBC Capital Markets ...
Toast (NYSE:TOST) Coverage Initiated at BMO Capital Markets
Research analysts at BMO Capital Markets began coverage on shares of Toast (NYSE:TOST – Get Free Report) in a report released on Monday,Benzinga reports. The brokerage set an “outperform” rating and a ...